Javascript must be enabled to continue!
Relevant SARS‐CoV‐2 Genome Variation through Six Months of Worldwide Monitoring
View through CrossRef
Real‐time genome monitoring of the SARS‐CoV‐2 pandemic outbreak is of utmost importance for designing diagnostic tools, guiding antiviral treatment and vaccination strategies. In this study, we present an accurate method for temporal and geographical comparison of mutational events based on GISAID database genome sequencing. Among 42523 SARS‐CoV‐2 genomes analyzed, we found 23202 variants compared to the reference genome. The Ti/Tv (transition/transversion) ratio was used to filter out possible false‐positive errors. Transition mutations generally occurred more frequently than transversions. Our clustering analysis revealed remarkable hotspot mutation patterns for SARS‐CoV‐2. Mutations were clustered based on how their frequencies changed over time according to each geographical location. We observed some clusters showing a clear variation in mutation frequency and continuously evolving in the world. However, many mutations appeared in specific periods without a clear pattern over time. Various important nonsynonymous mutations were observed, mainly in Oceania and Asia. More than half of these mutations were observed only once. Four hotspot mutations were found in all geographical locations at least once: T265I (NSP2), P314L (NSP12), D614G (S), and Q57H (ORF3a). The current analysis of SARS‐CoV‐2 genomes provides valuable information on the geographical and temporal mutational evolution of SARS‐CoV‐2.
Title: Relevant SARS‐CoV‐2 Genome Variation through Six Months of Worldwide Monitoring
Description:
Real‐time genome monitoring of the SARS‐CoV‐2 pandemic outbreak is of utmost importance for designing diagnostic tools, guiding antiviral treatment and vaccination strategies.
In this study, we present an accurate method for temporal and geographical comparison of mutational events based on GISAID database genome sequencing.
Among 42523 SARS‐CoV‐2 genomes analyzed, we found 23202 variants compared to the reference genome.
The Ti/Tv (transition/transversion) ratio was used to filter out possible false‐positive errors.
Transition mutations generally occurred more frequently than transversions.
Our clustering analysis revealed remarkable hotspot mutation patterns for SARS‐CoV‐2.
Mutations were clustered based on how their frequencies changed over time according to each geographical location.
We observed some clusters showing a clear variation in mutation frequency and continuously evolving in the world.
However, many mutations appeared in specific periods without a clear pattern over time.
Various important nonsynonymous mutations were observed, mainly in Oceania and Asia.
More than half of these mutations were observed only once.
Four hotspot mutations were found in all geographical locations at least once: T265I (NSP2), P314L (NSP12), D614G (S), and Q57H (ORF3a).
The current analysis of SARS‐CoV‐2 genomes provides valuable information on the geographical and temporal mutational evolution of SARS‐CoV‐2.
Related Results
The Potential of Medicinal Plants and Bioactive Compounds in the Fight Against COVID-19
The Potential of Medicinal Plants and Bioactive Compounds in the Fight Against COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus , is causing a serious worldwide COVID-19 pandemic. The emergence of strains with rapid spread and...
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
Abstract
Introduction
Human immunodeficiency virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) surface glycoproteins, including shared epitope motifs, sho...
Kinetics of the humoral immune response to SARS-CoV-2: comparative analytical performance of seven commercial serology tests
Kinetics of the humoral immune response to SARS-CoV-2: comparative analytical performance of seven commercial serology tests
Abstract
Background
SARS-CoV-2 serology tests are clinically useful to document a prior SARS-CoV-2 infection in patients with n...
Mutations in SARS-CoV
Mutations in SARS-CoV
The coronavirus family is named for the large spike protein molecules found
on the pathogen exterior, which give the virus a crown-like appearance, the coronavirus
genome is the bi...
From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes
From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes
AbstractBackgroundSevere acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is an emerging disease with fatal outcomes. In this study, a fundamental knowledge gap question is to...
Performance characteristics of the VIDAS® SARS-COV-2 IgM and IgG serological assays
Performance characteristics of the VIDAS® SARS-COV-2 IgM and IgG serological assays
ABSTRACTThe COVID-19 pandemic, caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread worldwide. Serological testing for SARS-CoV-2-spe...
P-003 Impact of SARS-CoV-2 infection on circulating male sex hormones and human semen quality: a systematic review and meta-analysis
P-003 Impact of SARS-CoV-2 infection on circulating male sex hormones and human semen quality: a systematic review and meta-analysis
Abstract
Study question
Does SARS-CoV-2 infection alter human male sex steroid hormones and semen quality?
...
Analyses of the Spike Proteins of Severe Acute Respiratory Syndrome-Related Coronaviruses
Analyses of the Spike Proteins of Severe Acute Respiratory Syndrome-Related Coronaviruses
Aim: To analyze spike proteins of Severe Acute Respiratory Syndrome (SARS)-related coronaviruses (CoVs) for their conserved motifs, Receptor-Binding Domain (RBD), Receptor Binding...

